Dermal equivalent with melanoma as a platform to screening antitumoral molecules (2012)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: ANTINEOPLÁSICOS, MELANOMA
ABNT
SANTOS, Manoela Tiago dos et al. Dermal equivalent with melanoma as a platform to screening antitumoral molecules. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 ago. 2024. , 2012APA
Santos, M. T. dos, Brohem, C. A., Oliveira, E. M. de, Campa, A., Barros, S. B. de M., & Maria-Engler, S. S. (2012). Dermal equivalent with melanoma as a platform to screening antitumoral molecules. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Santos MT dos, Brohem CA, Oliveira EM de, Campa A, Barros SB de M, Maria-Engler SS. Dermal equivalent with melanoma as a platform to screening antitumoral molecules. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 29 res.FCF053 .[citado 2024 ago. 23 ]Vancouver
Santos MT dos, Brohem CA, Oliveira EM de, Campa A, Barros SB de M, Maria-Engler SS. Dermal equivalent with melanoma as a platform to screening antitumoral molecules. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 29 res.FCF053 .[citado 2024 ago. 23 ]